BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25023382)

  • 1. Molecular biology of pancreatic ductal adenocarcinoma.
    Coleman SJ; Rhim AD
    Curr Opin Gastroenterol; 2014 Sep; 30(5):506-10. PubMed ID: 25023382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.
    Hernández-Muñoz I; Skoudy A; Real FX; Navarro P
    Pancreatology; 2008; 8(4-5):462-9. PubMed ID: 18724072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.
    Funel N; Giovannetti E; Pollina LE; del Chiaro M; Mosca F; Boggi U; Campani D
    Expert Rev Mol Diagn; 2011 Sep; 11(7):695-701. PubMed ID: 21902531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer gene profiling in pancreatic cancer.
    Vilardell F; Iacobuzio-Donahue CA
    Methods Mol Biol; 2010; 576():279-92. PubMed ID: 19882267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of pancreatic ductal carcinoma: a review.
    Sohn TA; Yeo CJ
    Surg Oncol; 2000 Nov; 9(3):95-101. PubMed ID: 11356337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
    Malla RR; Kumari S
    Crit Rev Oncog; 2019; 24(2):119-132. PubMed ID: 31679207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel targets in pancreatic cancer research.
    Kozak G; Blanco FF; Brody JR
    Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.
    Wescott MP; Rustgi AK
    Cancer Prev Res (Phila); 2008 Dec; 1(7):503-6. PubMed ID: 19138999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of pancreatic cancer--new aspects and targets.
    Schneider G; Hamacher R; Eser S; Friess H; Schmid RM; Saur D
    Anticancer Res; 2008; 28(3A):1541-50. PubMed ID: 18630509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution.
    Gutiérrez ML; Sayagués JM; Abad Mdel M; Bengoechea O; González-González M; Orfao A; Muñoz-Bellvis L
    Histopathology; 2011 Feb; 58(3):486-97. PubMed ID: 21323969
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis.
    Felsenstein M; Hruban RH; Wood LD
    Adv Anat Pathol; 2018 Mar; 25(2):131-142. PubMed ID: 28914620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in microRNA in pancreatic ductal adenocarcinoma].
    Yu CK; Yu SN; Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):575-81. PubMed ID: 22338146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.